LinkedIn Icon
March 26-28, 2019 | Boston, MA

Start-Up Focus Evening

How can academic promise translate into commercial success?

What challenges have start-up companies in this field faced and how have they overcome them? These are just some of the questions that this dedicated focus evening will address, enabling you to understand how young companies are establishing themselves in this rapidly-evolving field. This intimate evening of case-study led presentations and open, frank discussions will enable you to learn from experts who have experienced the reality of establishing successful companies first-hand.

The start-up focus evening will take place on Tuesday, March 26 after the pre-conference workshops.

4:30pm Chair’s Opening Remarks

4:45pm Deep Dive: The Realities of What Can & Should Truly be Outsourced

Eric David, BridgeBio

5:00pm The Value of Physician & Scientist Collaborations in Designing Gene Therapy Drugs

Rajendra Kumar-Singh, Tufts University and Hemera Biosciences

5:15pm Presentation Title to be Confirmed

Sean Ainsworth, Immusoft

5:30pm Panel Discussion

Collectively discuss the gene therapy field and share experiences in overcoming key early stage challenges. Gain insights and perspectives from stakeholders at a range of different stages of development in the field and benchmark your progress against a variety of companies and organizations.

Satinder Rawat, UMass Medical School
Eric David, BridgeBio
Rajendra Kumar-Singh, Tufts University and, Hemera Biosciences
Sean Ainsworth, Immusoft

6:15pm Chair’s Closing Remarks